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Contact dermatitis is one of the most common occupational diseases.  
Absenteeism of the affected workers and associated health care costs makes this disease 
an economically important issue.  Irritant contact dermatitis (ICD) is a common contact 
dermatitis observed among workers.  As each category of irritants triggers the 
inflammatory process by different method, studying the mechanism of ICD is difficult.  
Information on the mechanism of action of an irritant is indispensable for the 
development of effective prophylactic and therapeutic measures.  In this study, we have 
investigated the early changes in rat skin induced by jet fuel-8 (JP-8).  Although previous 
studies have described the cytokines involved in the latter phase of the inflammatory 
process induced by JP-8, there is no information on the molecular mechanisms that leads 
to the downstream events.  Gallucci et al., (2004) and Chatterjee et al., (2006) has shown 
that JP-8 induces elevated levels of interleukin-1α (IL-1α) in skin and cultured 
keratinocytes, respectively.  The preformed and stored proinflammatory cytokine, IL-1α 
that has autocrine and paracrine functions, appear to trigger the cascade of events that 
leads to the JP-8-induced contact dermatitis.  We hypothesize that JP-8 induces increased 
levels of IL-1α at early post-exposure time points.  To test our hypothesis, we applied JP-
8 in an occlusive patch for 1 h on the rat skin and measured IL-1 at 0, 1, 2, 3, 4, and 8 h 
post exposure.  Neutrophils infiltrate the skin during the late phase of the inflammatory 
process; therefore we studied the neutrophil infiltration during the selected time points 
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and measured the levels of CXCL2, the cytokine associated with the infiltration of 
neutrophils.  Preformed and stored IL-1 might play an important role in the JP-8 induced 
gene expression in skin.  We hypothesized that that blocking of IL-1 receptor will inhibit 
the JP-8 induced gene expression pattern.  To test our hypothesis, we delivered IL-1 
receptor antagonist into the skin before JP-8 treatment.  We found that At 3 h post 
exposure, IL-1α was reduced in JP-8 exposed skin and the selected time points were too 
early in the inflammatory cascade to reveal infiltration of neutrophils, although there was 
a slight increase in the level of CXCL2 at 2 h post exposure.  Because IL-1β has similar 
biological effects, we measured this cytokine from the same samples used for IL-1α 
quantification.  IL-1β did not significantly change throughout the study.  The decrease in 
the level of IL-1α implies that JP-8 induces the release of the preformed IL-1α.  IL-1 
receptor antagonist did not cause significant changes in the gene expression pattern.  We 
conclude that the release of the preformed IL-1α by JP-8 is one of the important events at 
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An inflammatory response in the skin resulting from contact with external factors 
is termed contact dermatitis (Fyhrquist-Vanni et al., 2007).  Contact dermatitis forms 
30% of all occupational diseases (Diepgen and Coenraads, 1999).  Worldwide about 4 
million working days are lost each year due to absenteeism of the affected workers 
(English, 2001; English, 2004).  The economic damage from health care costs and loss in 
labor hours due to contact dermatitis makes it an important issue.  Contact dermatitis 
triggered by antigen is termed as Allergic Contact Dermatitis (ACD)  (Beltrani and 
Beltrani, 1997).  A non-immunologic, local, reversible, inflammatory reaction due to 
repeated or single contact to the skin is referred to as Irritant Contact Dermatitis (ICD) 
(Corsini and Galli, 2000).  ICD is the most common form of contact dermatitis in the 
work environment (Elsner, 1994).  Although ICD is a major health problem, the 
molecular mechanism underlying this process is yet to be clearly understood (Chew and 
Maibach, 2006).  Jet propulsion fuel-8 (JP-8) causes contact dermatitis (Gallucci et al., 
2001; McDougal et al., 2007).  A Single exposure of skin to JP-8 triggered gene 
expression of inflammatory proteins (McDougal et al., 2007).  Contact dermatitis 
resulting from an allergic reaction requires multiple exposures.  Therefore, the changes 
documented in the single-exposure gene expression studies imply that JP-8 may cause 
ICD.  In this study, we have investigated the change in the levels of inflammatory 






JP-8 is used in aircraft, ground vehicles, cooking stoves, and personnel heaters by 
the militaries of the United States and the North Atlantic Treaty Organization (NATO). 
About 5 billion gallons of JP-8 is used every year, and there is a widespread exposure of 
the military personal.  JP-8, a kerosene based fuel, is a complex mixture of hydrocarbons 
containing about 200 aromatic and aliphatic hydrocarbons.  Because JP-8 is a 
performance based fuel, the composition of the components may differ from region to 
region (Subcommittee on Jet-Propulsion Fuel, 2003).  Therefore, the US Air Force 




Figure 1: Cartoon of normal human skin showing epidermis (E), dermis (D), 
subcutaneous fat layer (SCFL), and skin appendages including hair follicle (HF), 
sebaceous gland (SG), eccrine sweat gland (ESG), Meissner’s corpuscle (MC), pacinian 
corpuscle (PC), blood vessels (BV), sweat glandn pore (P), nerve fiber (NF), free nerve 
ending (FNe).  Picture and legend adapted from (Tobin, 2006). 
 
Skin is the largest organ of the body.  As the interface between the external 
environment and our body, the skin is the first organ to encounter environmental stressors 
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(Tobin, 2006).  Skin acts as a protective barrier to many physical, chemical, and 
biological stressors.  The epidermis and the dermis form the skin (Feinkel and Woodley, 
2001).  The outer epidermal layer is formed of stratified, keratinized epithelium.  The 
keratin producing cells, keratinocytes, are the major cell type found in the epidermis.  
The antigen presenting Langerhans cells, the pigment producing Melanocytes, and the 
sensory Merkel cells are the other type of cells present in the epidermis (Tobin, 2006).   
  The dermis, a connective tissue that supports the epidermis, is composed of 
fibrous and amorphous extracellular matrix.  The dermis may be divided into two main 
regions: the upper papillary dermis, which consists of high density of fibroblastic cells 
capable of more rapid proliferation, and the lower reticular dermis composed of large-
diameter collagen and elastin fibrils. The dermis consists of epidermal derived 
appendages, neurovascular networks, sensory receptors, and dermal cells that include the 
bone marrow-derived mast cells and macrophages.  The mast cells and macrophages play 
an active role in allergic reactions.  Monocytes from blood migrate to the dermis and 
differentiate into macrophages.  The phagocytic macrophages may act as antigen 
presenting cells (Seeley et al., 1995; Tobin, 2006). 
 
Cytokines in irritant contact dermatitis 
The mechanism of chemically induced ICD is yet to be documented (Corsini and 
Galli, 1998).  The hypothetical sequence of events is shown in figure 2.  ICD is identified 
only by excluding other causes, such as ACD, by skin patch testing (Elsner, 1994).  
Substances that can dissolve keratin, dehydrate the skin and cause physical injury in the 
skin cells induces ICD (Beltrani and Beltrani, 1997).  Substances such as detergents, 
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solvents, and oils cause inflammation through different mechanisms, making the study of 
biochemical mechanisms involved in skin irritation extremely complex (Corsini and 
Galli, 1998).  ICD is a complex process that involves epidermal and dermal cells as well 
as migrating leukocytes.  During inflammation, the epidermis and the dermis 
communicate with each other by secretion of cytokines. Cytokines are signaling 
molecules ranging from 6 kDa to 60 kDa.  Chemicals that trigger ICD, in addition to 
damaging the tissue, can also alter or induce the release of cytokines (Corsini and Galli, 
1998).  The chemicals can also induce epidermal keratinocytes to release stored 
inflammatory cytokines IL-1 and TNFα. (McKenzie and Sauder, 1990).  The following 
figure shows the hypothetical sequence of events occurring in ICD. 
 
 




The important cytokines in ICD are the interleukin-1 family and Tumor necrosis 
factor-α (TNF-α) (Chew and Maibach, 2006). The IL-1 family consists of IL-1α , IL-1β 
and an IL-1 receptor antagonist (IL-1ra).  In the skin, IL-1 is produced by dendritic cells, 
keratinocytes, Langerhans cells, melanocytes, fibroblasts and endothelial cells (Dinarello, 
1994).  IL-1 is released from skin in response to irritants such as benzalkonium chloride 
and sensitizers such as oxazolone (Wilmer et al., 1994). The biological effects of IL-1α 
and IL-1β are very similar although they share only 30% of amino acid sequence 
(Dinarello, 1996).  IL-1α and IL-1β are synthesized as 33 kDa precursor molecules.  
Both the pro-IL-1α and mature IL-1α are biologically active.  IL-1α lacks the 
hydrophobic leader sequence that is required for secretion, which may be the reason that 
preformed IL-1α is stored in the skin cells until the membrane integrity of the cell is 
compromised (Dinarello, 1997).  The IL-1β precursor is not biologically active until it is 
processed by IL-1β converting enzyme (Dinarello, 1996). Mature IL-1β is secreted from 
the cell.  IL-1α and IL-1β are initiators of the inflammatory cascade as they can rapidly 
trigger the transcription of a number of genes such as activator protein-1, NF-κB, and 
nuclear factor IL-6 (Bankers-Fulbright et al., 1996).  IL-1α and IL-1β also up-regulate 
the expression of cellular adhesion molecules on vascular endothelial cells (Detmar et al., 
1992).  There are two types of IL-1 receptors, type I and type II. IL-1 triggers signal 
transduction by binding to IL-1 receptor type I.  The type II receptor does not produce a 
known biological effect and acts as a decoy receptor in the negative feedback loop.  IL-
1ra binds to the type II receptor without triggering signal transduction.  When IL-1ra 
binds to the receptor it prevents the interaction of IL-1α and IL-1β with the receptors.  
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Thus, IL-1ra provides  negative feedback for IL-1 signaling (Feinkel and Woodley, 
2001).  
TNF-α, a multifunctional cytokine, is produced in skin by dendritic cells, 
keratinocytes, fibroblasts and mast cells (Kock et al., 1990; McKenzie and Sauder, 1990).  
Protein and mRNA levels of TNF-α were increased when normal human keratinocytes, 
were exposed to ultra violet-B light and lipopolysacchride in vitro (Kock et al., 1990).  
TNF-α up-regulates cellular adhesion molecules on the surface of vascular endothelial 
cells, thereby contributing to the accumulation of leukocytes at the sites of inflammation 
(Detmar et al., 1992).  TNF-α also stimulates the secretion of other inflammatory 
cytokines such as IL-1 and IL-6 resulting in the amplification of the biological effects 
(Luheshi and Rothwell, 1996).  The binding of TNF-α to its receptor increases the 
activity of specific target genes such as nuclear factor kappa B (NF-κB).  NF-κB 
regulates the transcription of other inflammatory molecules such as IL-1 (Bazzoni and 
Beutler, 1996; Corsini et al., 1997; Hohmann et al., 1990; Karin and Ben-Neriah, 2000).  
Although TNFα is an important cytokine in the inflammatory process, irritants like 
benzalkonium chloride do not appear to induce significant TNFα production in the skin 
(Corsini and Galli, 1998). 
 
Cytokine expression in response to JP-8 exposure 
JP-8 is one of the fuel oils primarily used by the military.  JP-8 causes contact 
dermatitis (Gallucci et al., 2004; Kabbur et al., 2001; McDougal et al., 2007; Rogers et 
al., 2001; Rogers et al., 2004).  Brief exposure to JP-8 causes inflammation in skin that 
may be due to change in homeostasis of osmotic, oxidative, and membrane stability 
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(McDougal et al., 2007).  Cultured human neonatal epidermal keratinocytes up-regulated 
IL-8 when treated with 0.1% JP-8 for 24 h (Witzmann et al., 2005).  JP-8 induced 
increased expression of TNFα in hairless mice, and in cultured EpiDerm human skin 
model (Chatterjee, A. et al., 2006).  Three hundred µL of JP-8 applied on the back of rats 
in the neck region for seven days, induced up-regulation of cytokines such as growth 
related oncogene-α and –β, monocyte chemotactic protein-1, macrophage inflammatory 
protein -1α and -1β, eotaxin, IL-1β, and IL-6 (Gallucci, R.M. et al., 2004).  After 1 h 
exposure of JP-8 to rat skin, mRNA expression of amphiregulin, CCL2, CCL3, CCL4, 
CXCL1, CXCL2, IL-10, and IL-6 increased (McDougal, et al., 2007).  mRNA levels of 
S100 calcium binding protein A9 and CCL20 increased after 3 h post exposure 
(McDougal, et al., 2007). 
 
Potential mediators in JP-8 induced inflammation  
Another possible trigger in JP-8 induced ICD is reactive oxygen species (ROS).  
Skin, being at the interface between the environment and the body, is often exposed to 
pro-oxidant agents resulting in the generation of reactive oxygen species (Svobodova et 
al., 2006).  ROS are also generated in the skin as a part of self defense mechanism against 
invading pathogens.  Endogenously, ROS are produced in keratinocytes by aerobic 
respiration, enzymatic oxidation, xenobiotics and by infiltrating leukocytes (Darr and 
Fridovich, 1994; Fuchs and Milbradt, 1994).  However, excessive production of ROS is 
harmful for the tissue.  The antioxidant network in skin prevents the production of ROS 
and reduces damage to the tissue.  Superoxide dismutase converts reactive radicals to 
hydrogen peroxide and molecular oxygen.  Catalase, an enzyme of the antioxidant 
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network, breaks down the hydrogen peroxide into water and oxygen.  Another 
antioxidant enzyme is glutathione peroxidase (coupled with glutathione), which removes 
harmful hydrogen peroxides from the tissue.  Non-enzymatic systems such as alpha-
tocopherol (vitamin E), ascorbate (vitamin C) and urate regulate the activity of ROS. In 
the cells (Winyard et al., 2000).  ROS produces injurious effect when it overwhelms the 
antioxidant capacity of the skin (Briganti and Picardo, 2003) and plays a significant role 
in the inflammatory process.   
In the inflammatory cascade, ROS and cytokines are linked by Nuclear Factor-κB 
(NF-κB) complex.  The activation of NF-κB by ROS is one of the early events in the 
inflammatory reaction (Portugal et al., 2007).  Removal of the inhibitory protein IκB 
allows the translocation of NF-κB resulting in the activation of target genes (Allen and 
Tresini, 2000).  The genes for TNFα, IL-1, IL-6, IL-8 and inducible nitrous oxide 
synthase (iNOS) are transcriptional targets for NF-κB.  TNFα and IL-1 act as activators 
of NF-κB resulting in the positive feedback cytokine loop (Fuchs et al., 2001).  
 
Significance and Hypotheses 
IL-1α is an important inflammatory signaling protein which is preformed and 
stored in keratinocytes (Dinarello, 1997).  Gallucci et al., (2004) has shown that chronic 
exposure of JP-8 induced elevated level of IL-1β in the skin.  Twenty four hour after 
exposure to JP-8, cultured human keratinocytes upregulated IL-1α; however, the 
cytokine was below detectable level in the skin of the rats (Chatterjee et al., 2006).  
McDougal et al., (2007) has shown that 1h exposure of skin to JP-8 induces the mRNA 
expression of signaling proteins associated with IL-1α pathway. The role of IL-1α in 
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vivo, at the early time points after JP-8 exposure is yet to be documented.  In this study, 
we have investigated the changes in the level of IL-1α at the early time points after 1 h 
post exposure of JP-8.  The gene expression studies (McDougal et al., 2007) and 
keratinocytes cell culture studies (Chatterjee et al., 2006) suggest that the level of IL-1α 
may increase after brief exposure to JP-8.  We hypothesized that the IL-1 level 
increases in rat skin after 1 h exposure of JP-8. Our Specific aim 1 was to measure 
the IL-1α and IL-1β in control and JP-8 exposed skin at 0, 1, 2, 3, 4, and 8 post 
exposure time point. 
 
JP-8 induced inflammation is associated with neutrophil infiltration (Gallucci et 
al., 2004).  CXCL2 induces neutrophil infiltration (Watanabe et al., 1991).  After 1, 4 and 
8h exposure to JP-8, levels of CXCL2 mRNA increased 54.9, 26.2, and 16.8 fold 
respectively (McDougal et al., 2007).  The expression of CXCL2 and neutrophil 
infiltration indicates the advanced stage of inflammatory process.  In UV induced ICD, 
neutrophil infiltration occurred before 8 h in the dermis; within 24 h neutrophils 
infiltrated the epidermis (Fisher et al., 2001).  To identify the early indications of the 
inflammatory process we monitored the time points at which CXCL2 was expressed and 
neutrophil infiltration occurred.  Although there was significant up-regulation of the 
CXCL2 gene immediately after JP-8 exposure (McDougal et al., 2007), the protein 
expression of the signaling molecule and its impact on neutrophil infiltration at the early 
time points after JP-8 exposure were yet to be documented.  CXCL2 protein expression 
may be increased after the 1 h exposure of JP-8, followed by neutrophil infiltration.  We 
hypothesized that protein levels of CXCL2 will increase followed by neutrophil 
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infiltration after 1 h exposure of JP-8 and tested it in the following aims 2 and 3.  
Specific aim 2 was to measure CXCL2 in control and JP-8 exposed skin at 0, 1, 2, 3, 
4, and 8 post exposure time points, while Specific aim 3 was to identify the time 
point at which neutrophils infiltrate into the skin. 
One-hour exposure of JP-8 to rat skin was shown to result in changing of the transcripts 
of proteins involved in ERK/MAPK, IL-6, PDGF, P38, MAPK, IGF-1, EGF, IL-2, 
JAK/stat, and Neurotrophin/Trk pathways (McDougal et al., 2007).  A one-minute JP-8 
exposure has been shown to induce up-regulation of genes involved in basal transcription 
and translations, and down-regulation of genes related to DNA repair, metabolism, and 
keratin in cultured human epidermal keratinocytes (Chou et al., 2006).  The changed 
transcripts are monocyte chemotactic protein-1 (ccl2), cyclin-dependent kinase inhibitor 
1A (CDKN1A),  DNA-damage-inducible transcript 3 (DDIT3), Dual specificity 
phosphatase 1 (DUSP1), DUSP6, v-fos, FBJ murine osteosarcoma viral oncogene 
homolog (FOS), heat shock 27kDa protein 1 (HSPB1), jun oncogene (JUN), v-myc 
myelocytomatosis viral oncogene homolog (MYC), Phosphoinositide-3-kinase, 
regulatory subunit 2 (PIK3R2), Suppressorof Cytokine Signaling 3 (SOCS3), tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein - gamma polypeptide 
(YWHAG) (McDougal et al., 2007). If the gene expression related to inflammatory 
process, is triggered by IL-1α, that has been preformed and stored in epidermis, then 
blocking the receptor of IL-1α should change the gene expression pattern.  We 
hypothesized that blocking of IL-1 receptor will inhibit the JP-8 induced gene 
expression pattern.  The changes in the levels of the cytokines and the gene expression 
pattern induced by the cytokine will help us to understand the molecular mechanism of 
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JP-8 induced skin inflammation.  Understanding the molecular mechanism of the 
inflammatory process is an important step to develop therapeutic and preventive 
measures of JP-8 induced skin inflammation.   
12 
 
Materials and Methods 
Animals: Male Fischer rats (CDF/CrlBR, Charles River Laboratories, 250-350 g) 
was housed one per cage with 12 h day and night cycle.  The rats were acclimatized for 3 
days before the study.  Food and water was provided ad libitum.  The number of animals 
was selected based on the recommendation from Statistical Consulting Center at Wright 
State University.   
Exposure study: A Hill Top ChamberTM (Lomir Biomedical, Inc., Quebec 
Canada) containing five hundred microliters of JP-8 or an empty chamber (sham) was 
placed on the skin.  The chamber was held by duct tape as shown in Figure 3. 
 
Figure 3: Exposure setup.  The length of the ruler in the picture is 15 cm. 
 
After the exposure period, the animals were humanely killed using CO2 at time points 





Figure 4:  Timeline for exposure study 
 
Dissection of skin: After removing the Hill Top Chamber, we removed the 
residual JP-8 using cotton gauze.  For the control, we wiped the skin under the chamber 
using cotton gauze.  We marked the area under the chamber using a permanent marker.  
The exposed skin was surgically removed after humanely killing the animals using CO2. 
The underlying fascia and fat of the skin were removed using a single-edged razor blade 
(Industrial Razor Blades – single edged No. 9, VWR Scientific, Media, PA). An eight-
millimeter biopsy punch (using Uni-Punch, Plymouth Meeting, PA) was taken from the 
injected region of the skin.  The biopsy punches were flash frozen in liquid nitrogen.   
Total protein isolation and estimation: One hundred mg of frozen tissue was 
pulverized in Bessman tissue pulverizer (Fisher Scientific, Pittsburgh, PA) pre-cooled 
with liquid nitrogen.  The tissue was homogenized using Tissue Tearor (Model 985-370, 
Biospec Products) in a round-bottom 5 mL tube containing 1 mL of PBS with 10 uL 
protease inhibitors (Sigma #P8340, St. Louis, MO). During homogenization, the sample 
the tube was kept in a small beaker full of ice to reduce heat build up. The homogenate 
was transferred to 1.5 ml microcentrifuge tubes and spun at 13,000 g for 15 minutes at 4 




3 h 0 h 1 h 2 h 4 h 8 h 18 h 24 h 
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was done by Bradford method using Protein Assay Kit from Bio-Rad Laboratories, 
Hercules, CA.  We used SpectraMax Plus 384 (Molecular Devises, Sunnyvale, CA) to 
read the colorimetric changes at 595 µm in the assay. 
ELISA: Sandwich ELISA was used to quantitate IL-1α, IL-1β, and CXCL2 
protein levels.  The antibodies and standards were purchased from R & D systems, 
Minneapolis, MN.  Table 2 provides the information on the proteins used for the assay. 
Table 1: Primary and detection antibodies 





1 IL-1α MAB 500 BAF 500 500 RL 
2 IL-1β AF501NA BAF 501 501 RL 
3 CXCL2 MAB 525 BAF 525 525 RL 
 
The lowest dilution of antibody pair from the optimization table (Table 6 to 8 
given in the appendix) was selected and tested for consistency of the standard curve.  The 
process was repeated for each lot of the antibody.  The optimized amount of capturing 
antibody, diluted in 1x PBS, 100 μL per well, was incubated at room temperature 
overnight. Each well was washed with wash buffer (1x PBS with 0.5% Tween 20) three 
times using a plate washer (ELx50, Bio-teck, Winooski, VT).  Antibody coated wells 
were blocked using 1% BSA.  Blocking was carried out at room temperature for an hour.  
We washed the wells three times with wash buffer after blocking.  Standards or sample in 
an appropriate dilution were added to each well (100 µL) and incubated for 2 hours at 
room temperature.  After washing the wells three times in wash buffer, detection 
antibody, in the recommended dilution, was added to each well (100 µL) and incubated 
for 2 hours in room temperature.  The wells were then washed three times with wash 
buffer and the substrate (DY998, R&D systems, Minneapolis, MN) was added to each 
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well (100 μL).  After 30 minutes incubation with the substrate, 50 µL of stop solution 
(DY994, R&D systems, Minneapolis) was added to each well and the plates were gently 
tapped to ensure through mixing.  The chromogenic reaction in the wells was read using a 
SpectraMax Plus 384 (Molecular Devises Sunnyvale, CA) at 450 nm. 
Histology: The tissue was fixed in 4% formaldehyde for 4 hours.  The fixed tissue 
was dehydrated in ethanol and embedded in paraffin by series of steps given in the Table 
2.   
Table 2: Dehydration and embedding steps 
Steps Tissue transferred to: Time 
1 50% Ethanol 1 hour 
2 70% Ethanol 1 hour 
3 95% Ethanol 1 hour 
4 100% Ethanol 45 minutes 
5 100% Ethanol 45 minutes 
6 100% Ethanol 45 minutes 
7 Xylene 1 45 minutes 
8 Xylene 2 45 minutes 
9 Xylene and paraffin 45 minutes 
10 Paraffin 1 45 minutes 
11 Paraffin 2 45 minutes 
 
Dehydrated tissues were embedded in paraffin blocks and cooled overnight at 
room temperature.  After cooling, the blocks were kept in the refrigerator overnight, 
trimmed, and sectioned 7 µm thick.  The sections were transferred to a warm water bath 
containing gelatin to remove the wrinkles.  Gelatin aids the attachment of sections to the 
slides.  The mounted sections were kept in oven, set at 40 °C overnight, to remove excess 
paraffin. The sections were then stained with hematoxylin and eosin and/ or Masson 
Trichrome using the steps given in Table 3 a, b and c.   
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Table 3a: Staining steps common to hematoxylin and eosin, and Masson 
Trichrome (Humason, 1979) 
Steps Sections transferred to: Time 
1 Xylene 2 minutes 
2 Xylene 2 minutes 
3 100% Ethanol 2 minutes 
4 100% Ethanol 2 minutes 
5 95% Ethanol 2 minutes 
6 70% Ethanol 2 minutes 
7 Rinse in tap water 2 minutes 
 
Table 3b: Staining steps for hematoxylin and eosin 
Steps Sections transferred to: Time 
8 Hematoxylin 30 seconds 
9 Distilled water 3 minutes 
10 50% Ethanol 2 minutes 
11 70% Ethanol 2 minutes 
12 Eosin 7 seconds 
13 95% Ethanol 2 minutes 
14 100% Ethanol 2 minutes 
15 100% Ethanol 2 minutes 
16 Xylene 2 minutes 
17 Xylene 2 minutes 
18 Mount in permount 2 minutes 
 
Table 3c: Staining steps for Masson Trichrome 
Steps Sections transferred to: Time 
8 Iron alum 2 minutes 
9 Running water 5 minutes 
10 Distilled water 2 minutes 
11 Hematoxylin 30 seconds 
12 Running tap water 2 minutes 
13 Acid Fuschin 15 seconds 
14 Distilled water 2 minutes 
15 Ponceau de Xylidene 4 minutes 
16 Tap water 1 minute 
17 Phosphomolybdic acid 5minutes 
18 Fast green 30 seconds 
19 Acid water 1 minute 
20 70% Ethanol 1 minute 
21 95% Ethanol 1 minute 
22 100% Ethanol 2 minutes 
23 100% Ethanol 2 minutes 
24 Xylene 2 minutes 
25 Xylene 2 minutes 




Receptor antagonist:  We used Kineret (Anakinra), from Amgen, Thousand 
Oaks, CA, as IL-1α receptor antagonist. 
Tempol: We used tempol (4-hydroxy-2,2,6,6-tetramethylpiperydine-1-oxyl) from 
Sigma (catalog #56516), St. Louis, MO, antioxidant in our related study. 
Intradermal injection: The rats were anesthetized using Isoflurane (1-chloro 
2,2,2-trifluoroethyl difluoromethyl ether) before intradermal injection. After carefully 
clipping the fur on the back of the rat, a needle (0.3 mm thick and 19 mm long) was 
inserted subcutaneously, about 1.5 centimeters away from the site of injection with the tip 
of the needle brought up towards the epidermis. We injected 100 µl of receptor antagonist 
or phosphate buffered saline.  By this method of intradermal injection, we prevented 
puncturing the barrier layer (stratum corneum) and reduced the possibility of the JP-8 
entering through a disrupted barrier. 
Immunohistochemistry: One hour after the injection, we removed the skin and 
flash froze it in liquid nitrogen.  The frozen tissues were sectioned at 20 µm and fixed in 
4% paraformaldehyde.  The paraformaldehyde fixed sections were permeabilized using 
0.1% triton X-100 for 2 minutes. The tissue was blocked with 5% donkey serum for 1h, 
and 1% non-fat dry milk for half an hour. We incubated the tissue with the primary 
antibodies at room temperature overnight.  The primary and secondary antibodies were 
optimized and appropriate working concentrations were selected.  For optimization the 
antibodies we used semi-log dilution of the antibodies including the recommended 
concentration as the median value in the series. Primary antibodies were Spring 
Bioscience #E2624 ((rabbit anti-human, , 0.67 µg/ml) for Keratin-14, which is specific 
for basal keratinocytes; Gene Tex #1.384.92.17.19 (mouse anti-human, 10 µg/ml), for IL-
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1ra; and R&D Systems #AF771 (goat anti-mouse, 1 µg/ml) for IL-1R1. Antibodies raised 
in donkey (Molecular Probes #A21207, #A31570, #A11055) labeled with Alexa Fluor 
594 (red), 555 (orange) or 488 (green) for Keratin-14, IL-2ra, and IL-1R1 , respectively 
were used as secondary antibodies.  Vectashield mounting media with DAPI (H-1200) 
was used and the slides were viewed with a Leica fluorescent microscope. 
Image analysis:  We used Image-proplus software (version 3.0 for windows, 
Media cybernetics, Silver spring, MD) to measure the length of the epidermis.  The 
histological-photomicrographs of the skin were loaded to the software and using a tracing 
tool the contour of the outermost nucleated layer of the epidermis was traced.  The length 




Figure 5.  Image Analysis: Epidermis of 1 cm skin was measured using a tracing tool 
from the Image proplus software.  The dark curved line in the image is the tracing line. 
 
Gene expression study: We injected 100 µl of IL-1α receptor antagonist or the 
phosphate buffered saline in the rat skin.  After one hour, we placed 500 µl of JP-8 on the 
injected area using Hill top chamberTM.   We removed the chambers after 1 h and 






muscle fascia and flash froze the skin in liquid nitrogen (figure 5).  Total RNA isolation 
was carried out used TRIreagent (Molecular Research Center, Cincinnati, OH).  The 
isolated RNA was cleaned up using the RNeasy Mini Kit (Qiagen, Valencia, CA) 
according to the manufacturer’s instructions. The concentration and the quality of total 
RNA was determined using the Experion RNA Standard Sensitivity chips in the Experion 
Automated Electrophoresis System (Bio-Rad, Hercules, CA).  
 
Figure 6: Injection, exposure and skin collection time points 
 
To generate double-stranded cDNA we used a Superscript II cDNA synthesis kit 
(Invitrogen, Carlsbad, CA) with an oligo(dT)24 primer containing a T7 RNA polymerase 
promoter binding site (Invitrogen).  The double-stranded cDNA was used to prepare 
labeled cRNA.  The labeling of cRNA was done in vitro transcription using a T7 
polymerase (MEGAscript T7 kit; Ambion) in the presence of biotin-11-CTP and biotin-
16-UTP (Enzo Diagnostics, Farmingdale, NY) and purified using RNeasy columns 
(Qiagen). The labeled (biotinylated) cRNA was fragmented and hybridized to rat 230 2.0 
GeneChip arrays (Affymetrix, Santa Clara, CA).  The gene chips contain probe sets for 
IL-1α ra injection  
 
Removal of JP-8 
treatment 
 
Collection of skin 
1 h post exposure 
 




about 31,000 genes. As per the recommended protocol we carried out chip hybridization, 
washing, and staining. The chips were scanned and the digitalized image data was 
processed using GCOS software from Affymetrix.  The data were analyzed using 
GeneSpring GX 7.3 (Agilent Technologies, Palo Alto, CA). 




Interleukin-1 expression in response to JP-8 exposure 
To test whether JP-8 induces the increase of IL-1 in skin, we measured IL-1α and 
 
Figure 7a: Experiment to determine the effect of JP-8 on IL-1α:  IL-1α was reduced at 
3h post exposure in JP-8 exposed skin. 
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IL-1β at 0, 1, 2, 3, 4, and 8 h post exposure to JP-8.  Six rats were used in each 
experiment. Each rat received control and JP-8 exposure.  We expected to see increases 
in the level of IL-1 in rat skin after 1 h of exposure to JP-8.  A consistent trend in the 
reduction of IL-1α was observed at 3h post exposure in JP-8 exposed skin (Figure 7a and 
7b).  IL-1α did not show a consistent change at other time points (graph not shown).  IL-
1β did not change throughout the study (graph not shown).  
 
Neutrophil infiltration study: 
To test whether JP-8 induces the increase of, CXCL2 in skin we measured the 
cytokine at 0, 1, 2, 3, 4, and 8 h post exposure period of JP-8.   
 
Figure 8a: Experiment to determine the effect of JP-8 on CXCL2:  CXCL2 was 
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Figure 8b: Repetition of the experiment to determine the effect of JP-8 on CXCL2 at 2h 
post exposure. 
 
Six rats were used in each experiment. Each rat received control and JP-8 exposure.  A 
consistent trend in the increase of CXCL2 was observed at 2h post exposure in JP-8 
exposed skin (Figure 8a and 8b).  CXCL2 did not show a consistent change at other time 
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Figure 9a: 8h post exposure control 
 
Figure 9b: 8h post exposure JP-8 treated 
No increase in cell density is observed indicating lack of inflammatory infiltration of 
neutrophils.  The gaps in dermis and different shades of the collagen fibers are 










Figure 9c: 12h post exposure control 
 
Figure 9b: 12h post exposure JP-8 treated 
No increase in cell density is observed indicating lack of inflammatory infiltration of 
neutrophils.  The gaps in dermis and different shades of the collagen fibers are 









Figure 9e: 24h post exposure control Figure 9f: 24h post exposure JP-8 treated 
No increase in cell density is observed indicating lack of inflammatory infiltration of 
neutrophils.  The gaps in dermis and different shades of the collagen fibers are 







In the hematoxylin and eosin stained sections, the cell density between the control and 
the JP-8 exposed skin was not significantly different when observed under light 
microscope.  Figure 9 shows representative photomicrographs from 8, 12, and 24 h post 
exposure.  After the exposure period, we observed mild erythema under the JP-8 patch.  
In most of the cases, the erythema faded away within 1h.  In 8, 12, and 24h post exposure 
time points we did not find inflammatory neutrophil infiltration.  
 
Intradermal Injection 
Intradermal injection induced changes in skin 
Histological Changes 
We studied the possibility of using intradermal injection to deliver biomolecules 
for pharmacological manipulation of skin. As the epidermis is thin, injection of 
biomolecules was made in the dermis.  The intradermal injection resulted in the 












Figure 10: Bleb produced by modified intradermal injection on the back of rat. Fur was 
clipped before the injection. The ruler is graduated in centimeters.  A bleb resulting from 




In the artificially created blisters, the epidermal and dermal layers are separated. 
(Kennedy et al., 1999). The signaling sequence would be hindered if there is a separation 
of the epidermis from the dermis. To understand whether intradermal injection would 
result in the separation of epidermis and dermis, we studied the histological changes after 
intradermal injection. 
 
Figure 11a Figure 11b 
 
Figure 11a: Light Microscopy of control skin stained with Mason’s Trichrome.   
1 - Epidermis, 2 – dermis  
Figure 11a: Light Microscopy of IL-1 RA injected skin stained with Mason’s Trichrome. 
1 - Epidermis, 2 - Gaps in dermis resulted from (100 µL) injection  
Bar = 10 µm 
 
An intradermal injection looks like a blister (Figure 11a). However, the 
intradermal injection is different from a blister (Figure 11b), because there is no 
separation of epidermis from dermis.  The injected fluid created small pocket in the 
dermis by stretching the collagen rich layer.  The pockets of the injected fluid are formed 
near the site of injection which appears as a bleb from outside. The contour of the 
epidermis in the injected skin (Figure 11b) is less wavy compared to control skin (Figure 
11a).  Dermis in the injected tissue has gaps surrounded by collagen fibers which have 







 Morphological changes: Image analysis study of epidermis  
 To understand the morphological changes in the skin after intradermal injection 
we measured the length of the epidermis in control skin and injected skin.   





Replication Length of epidermis in 
injected skin (mm) 
Length of epidermis 
in control skin (mm) 
1 Upper back 
1 1.351 1.822 
2 1.738 1.975 
2 Upper back 
1 1.558 1.685 
2 1.507 1.737 
3 Upper back 
1 1.495 1.786 
2 1.565 1.661 
4 Upper back 
1 1.317 1.724 
2 1.289 1.764 
2 Lower back 
1 1.503 1.679 
2 1.525 1.788 
3 Lower back 
1 1.304 1.592 
2 1.326 1.638 
4 Lower back 
1 1.337 1.743 
2 1.452 1.658 
Average 1.477 1.732 
Variance 0.017 0.009 
 
One millimeter section of the skin was observed under the microscope.  Using the image 
analyzer software, we traced the topmost nucleated cell layer of the epidermis.  The 
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traced line was measured and the length of the line was recorded using the software.  
Measuring the length of the epidermis, in one unit length of the skin, in the injected skin 
and control skin helps us to understand whether intradermal injection has induced 
stretching of the epidermis.  The injections were made in the upper back and lower back 
of the animals.  We observed that intradermal injection made at various regions of the 
back of the rat induced stretching of the epidermis and did not induce separation of 
epidermis and dermis. 
Detection of injected Interleukin-1 receptor antagonist in skin 
To test whether the injected antagonist could reach the epidermis we probed the 
antagonist in the epidermis, after injection, using flurophore tagged antibody. Control 
tissue (Figure 12 a) and IL-1ra injected tissue (Figure 12 b) were both treated with 
primary and secondary antibody of IL-1ra and Keratin-14. 
 
Figure 12a Figure 12b 
Figure 12: Fluorescent Microscopy of control skin stained for Keratin-14 (red) in basal 
membrane and IL-1ra (orange). 1 - Basal membrane (a), and IL-1ra injected skin stained 
for Keratin-14 (red) and IL-1ra (orange). 1 - Basal membrane, 2 - IL-1ra in epidermis (b). 






Figure 13a Figure 13b Figure 13c 
Figure 13: Fluorescent Microscopy of IL-1ra injected skin immunostained for IL-1ra 
(orange) (a), of IL-1ra injected skin immunostained for IL-1R1 (green) (b) and of IL-1ra 
injected skin showing co-localization of IL-1R1 (green) and IL-1ra(orange) (c) . Bar = 5 
µm 
 
Compared to the control tissue, the injected tissue shows immunostaining for IL-1ra 
(orange) in the epidermis and dermis.  Keratin-14, in the basal membrane, appeared in 
both the control and injected tissue.  Figure 13 a shows the presence of IL-1ra (orange) in 
the injected skin.  In Figure 13 b, we can see the IL-1R1 (green). Figure 13 c is the 
overlay of Figure 13A and Figure 13 B showing the co-localization of IL-1R1 and the 
injected IL-1ra.   
 
Effect of blocking IL-1α pathway in JP-8 exposed skin 
If preformed IL-1α plays a role in the initial stage then blocking the activity of the 
cytokine should modify the early sequence of events.  To investigate the effect of IL-1α 
RA  (Kineret) on gene expression to JP-8 exposure, we injected 100 µl of IL-1α RA or 
phosphate buffered saline in to the rat skin.  We did not see changes in the ERK/MAPK, 
IL-6, PDGG, P38, MAPK, IGF-1, EGF, IL-2, JAK/stat, and Neurotrophin/Trk pathways 
induced by IL-1ra after 1 h exposure of JP-8.  A complete list of changed gene is 
provided in the appendix (Table 11).  Out of 31,000 genes only 170 genes show at least 
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two fold difference.  About 5 % of the genes may change by chance.  Any change that is 
less than 5 % may not be considered as reliable change in the gene expression.  We found 
that only 0.55 % genes have changed in our study.  Injection of the IL-1α RA did not 




 Reactive oxygen species: 
To understand the role of ROS in JP-8 induced inflammation, we delivered an 
antioxidant, Tempol (4-hydroxy-2,2,6,6-tetramethylpiperydine-1-oxyl) into the skin 
before JP-8 exposure.  For our study, we intradermally injected one hundred micro liters 
of phosphate buffered saline (sham) or tempol, into the skin. Five hundred microliters JP-
8, in a hill top chamberTM or an empty chamber was placed on the injected region for 1 h.  
After 2 h post exposure period the rats were humanly killed, using CO2, and the skin was 
dissected.  Interleukin 1 was measured as described earlier.  
The results obtained 1) for IL-1 alpha for each rat is shown in figures  14 (A-F) 
and the combined data for 6 rats, is shown in figure 15, and 2) for IL-1 beta, the raw data 
is shown for each rat in figures 16 (A-F) and the combined data for 6 rats, is shown in 









Figure 14 A.  Replication 1: Effect of tempol in JP-8 induced IL-1α changes in skin 
  






















































Figure 14 D.  Replication 4: Effect of tempol in JP-8 induced IL-1α changes in skin  
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3 Control 3 Tempol 5 mM 3 Tempol 25 mM 3 Tempol 50 mM















































Figure 15: Graphical representation of combined data. Error bar represents SD of n=6 
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Figure 16C. Replication 3: Effect of tempol in JP-8 induced IL-1β changes in skin 
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Figure 16 F. Replication 6: Effect of tempol in JP-8 induced IL-1β changes in skin 
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Figure 17: Graphical representation of combined data.  There is no significant difference 
between the groups.  Error bar represents ±SD of n= 6 
 
We observed a consistent trend of higher level of IL-1α in 5 mM and 50 mM compared 
to control and tempol 25 mM treated skin. However there was no significant change of 
expression of IL-1α and IL-β in JP-8 exposed skin in the tempol treatment.  Interestingly 
tempol, a well known ROS scavenger, did not produce a dose response.  For future study, 
efficacy of tempol in our model has to be evaluated.  We suggest the use of 
Lipopolysaccharide (LPS) triggered ROS system to evaluate the effectiveness of tempol. 
LPS is an inducer of ROS.  Studying the inflammatory response of LPS in tempol pre-
treated skin will aid us to understand the tempol’s ROS scavenging efficacy in our model.  
In future, the study should be repeated with LPS as a positive control to better understand 
the current data. 
 
Autocrine effect of IL-1α in JP-8 induced inflammatory process 
To understand the role of preformed IL-1α we injected IL-1α receptor antagonist (IL-1α 
RA) into the skin before JP-8 exposure.  IL-1α RA was injected into the skin in an 



























Control Tempol 5 mM Tempol 25 mM Tempol 50 mM
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attempt to block the activity of IL-1 Since we found decrease in IL-1α at 3 h post 
exposure to JP-8, we selected the time point for this study.   
 
We injected IL-1α RA and after 1h we did the exposure.  The exposure period 
was 1 h.  Three hours post exposure we humanely killed the animals, dissected the skin 






Figure 18: Injection, exposure and collection of skin 
 
 
Table 5: IL-1α expression in pg/mg of protein 
Replication RA Placebo JP-8 Control 
Rat 1 3.497 4.130 4.520 5.538 
Rat 2 3.883 4.428 6.998 5.222 
Rat 3 4.837 5.013 6.419 8.388 
Rat 4 3.675 5.872 4.619 6.783 
Rat 5 3.782 4.991 4.034 4.688 
Rat 6 3.162 4.566 4.957 3.619 
Average 3.806 4.833 5.258 5.706 
SD 0.565 0.611 1.176 1.674 
CV 14.844 12.638 22.370 29.332 
 
IL-1α RA injection  
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Figure 19:  IL-1 alpha expression in response to JP-8 exposure after interleukin 1 
receptor antagonist treatment.  Error bar represents ±SD of n= 6 
 
 The preliminary result shown in figure 19 and table 6 shows that the receptor 
blocking did not significantly alter the IL-1α in control and JP-8 exposed skin.  The 
efficacy of the receptor blocker has to be studied before we can make a conclusion in this 































In our study, we have shown that the level of IL-1α decreases in rat skin after 1h 
occlusive exposure of JP (Figure 7).  Chatterjee et al., (2006) have suggested that the 
level of IL-1α may increase after brief exposure of JP-8 to keratinocytes in vitro.  
Epidermal layer, where IL-1α is preformed and stored is primarily composed of 
keratinocytes.  We hypothesized that the IL-1 level increases in rat skin after 1 h 
exposure of JP-8.  At the 3h post exposure IL-1α decreased (Figure 7a and 7b).  IL-1α 
did not show a consistent change in other time points.  IL-1β levels did not show a 
significant change at any time point.  In normal murine skin, IL-1α was present in the 
dermis and nucleated epidermal layers in a diffused pattern (Wood et al., 1996).  Kabbur 
et al., (2001) have reported increases in the level of IL-1α after 1h exposure of skin to JP-
8.  Interestingly, our results indicate that preformed, stored IL-1α is released from the 
skin at 3 h in response to JP-8 exposure.  IL-1α when bound to IL-1 type I receptors in 
keratinocytes, activates interleukin-1 receptor associated kinase-1 pathway inducing 
downstream events of the inflammatory cascade (Sanmiguel et al., 2009; Stylianou and 
Saklatvala, 1998).  IL-1 regulates gene expression and cellular processes through 
activation of the transcription factors NF-κB and activator protein 1 complex (Verstrepen 
et al., 2008).  In response to mechanical insult to the epidermal layer, IL-1α level 
increased within 10 minutes and remained elevated at 2 and 4h time points.  As IL-1α 
release induces further synthesis of the cytokine in keratinocytes (Lee et al., 1991), we 
expected to see increasing levels of IL-1 after JP-8 exposure.  However, throughout the 
post-exposure study, IL-1α levels did not increase in the JP-8 exposed skin.  To prevent 
JP-8 contamination during protein isolation we removed the JP-8 residues on the skin by 
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wiping the skin with cotton gauze thoroughly.  However JP-8 enters into the skin (Kim et 
al., 2006)and skin remains in the tissue until removed by the system.  Therefore, one of 
the probable reasons for the reduced amount of IL-1α at the early post-exposure time 
points could be the presence of JP-8 in sample denaturing the cytokine or interfering with 
the estimation process of the cytokine.  To check whether the residual quantity of JP-8 
interferes with the assay, we may have to identify the quantity of JP-8 or its components 
left at each time points and spike the assay with the estimated quantity of JP-8 or its 
components.  We found in literature that the detection of elevated levels of cytokines in 
cultured human keratinocytes and in vivo study was not affected after JP-8 exposure 
study.  Cultured human keratinocytes after JP-8 exposure up-regulated IL-1α protein 
level at 24 h post exposure period (Chatterjee et al., 2006).  IL-1β protein level was 
elevated in the 7-day chronic exposure study. The cytokine estimation was carried out 
after 2 h following exposure to JP-8 (Gallucci et al., 2004).  Based on the above two 
studies it appears that measurement of IL-1 in the media or in the tissue is not impaired 
by the presence of residual amount of JP-8.   
We did not see changes in the levels of IL-1β in skin after JP-8 exposure.  
Chronic exposure of JP-8 induced increased levels of IL-1β in skin (Gallucci et al., 
2004).  Sanmiguel et al., (2009) have suggested that IL-1α may play a role in leukocyte 
recruitment in skin following the release of the cytokine, and IL-1β could play a role in 
the maintenance of inflammatory process.  The exact difference in the role of IL-1α and 
IL-1β in skin inflammation is yet to be established, although the suggestion of Sanmiguel 
et al., (2009) may explain the increased expression of IL-1β in the chronic exposure study 
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(Gallucci et al., 2004) and lack of change in the level of IL-1β in our acute exposure 
study. 
Inflammation is characterized by the infiltration of neutrophils.  CXCL2 is a 
cytokine induced by the proinflammatory cytokines.  CXCL2, also known as cytokine-
induced neutrophil chemoattractant-3, is the major neutrophil chemotactic factors in rats 
(Murakami et al., 1997).  CXCR2, the receptor of CXCL2, is expressed in normal 
epidermis and the level of the cytokine increases during the inflammation (Zaja-
Milatovic and Richmond, 2008).  In skin, the mRNA level of CXCL2 increased after 1h 
exposure of JP-8 (McDougal et al., 2007).  In our study, we found an increase of CXCL2 
at 2h post exposure time point (Figure 8).  Compared to the quantity of IL-1 in rat skin, 
the level of CXCL2 is very low.  Although there is slight increase in CXCL2 at the 2h 
time point we did not see significant neutrophil infiltration in JP-8 exposed skin.   
Gallucci et al., (2004) have observed that repeated exposure of JP-8 for 7 days 
induced neutrophil infiltration in rat skin.  We did not find neutrophil infiltration in the 
JP-8 exposed skin in 8, 12, 24 h post exposure.  UV rays, an irritant, induce neutrophil 
infiltration within 8h of skin exposure.  The lack of neutrophil infiltration in the skin 
suggests that single exposure of JP-8 may not induce infiltration of leukocytes or the 
inflammatory infiltration of cells does not occur before 24 h after the exposure.   
The reduction of IL-1α in JP-8 exposed skin indicates the release of preformed 
and stored cytokine.  If the released IL-1α is responsible for the trigger of the JP-8 
induced inflammatory cascade, then blocking of the pathway should induce changes in 
the downstream events. To block the IL-1 activity of IL-1α we delivered IL-1 receptor 
antagonist into the skin.  The intradermal injection produced a bleb similar in appearance 
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to a blister created by suction method (Kennedy et al., 1999).  In the artificially created 
blister, the epidermis and the dermis are separated by a fluid filled space.  To study the 
events in the inflammatory process we have to maintain the integrity of the epidermis and 
dermis.  The cell signaling between the two skin layers is indispensable for the 
inflammatory pathway.  Therefore, if the intradermal injection results in the separation of 
the epidermis and dermis then we may not be able to use the model to study JP-8 induced 
inflammation.  We studied the tissue sections of the skin under microscope after 
intradermal injection to understand the changes induced by intradermal injection.  
Compared to control sections large gaps were found in the dermis (Figure 11) between 
the collagen fibers in the injected skin.  The collagen fibers in the papillary dermis region 
appear to be stretched.  The epidermis in the injected skin was stretched as a result of 
bleb formation.  We compared the length of the epidermis in the control skin and the 
injected skin (Table 5).  We measured the length of the epidermis in 1 mm section of 
skin.  In the control skin, the contour of epidermis is convoluted and measured longer 
than the epidermis of the skin from bleb.  The intradermal injection did not separate the 
epidermis and dermis and found to be compatible for our study.  However, the 
intradermal injection can be considered successful only if the delivered molecules reache 
the epidermis.  In skin, IL-1 receptors are predominantly concentrated in the epidermis 
(Figure 13b).  Since the epidermis is thin, the injection has to be made in the dermis close 
to epidermis.  The tight junctions (Furuse et al., 2002) in the epidermis may hinder the 
movement of the antagonist into the upper layers.   
To study whether the injected antagonist could pass the basal layer of the 
epidermis and bind to the receptor, we probed the antagonist after injection.  We detected 
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the injected antagonist above the basal membrane of the epidermis (Figure 12b).  We 
tagged the basal membrane with keratine 14 antibody (Figure 12a).  Keratin-14 is found 
in the basal layer of epidermis.  Therefore, detection of the antagonist in the layers above 
the keratin-14 tagged region indicates that the antagonist could pass through the basal 
membrane of the epidermis.  We probed the injected skin with the IL-1 receptor and IL-1 
receptor antagonist antibody (IL-1ra) in the same sections.  The antibodies for both the 
receptors and the receptor antagonist were in close proximity indicating higher 
probability of the binding of the receptor and the antagonist (Figure 12c). 
To understand the role of IL-1 pathway in JP-8 induced gene expression pattern, 
we delivered IL-1ra into the skin before JP-8 exposure.  If preformed IL-1α plays a role 
in the initial stage then blocking the activity of the cytokine should modify the early 
sequence of events.  We did not see changes in genes expression pattern induced by 1h 
exposure of JP-8 (Table 11).  The inflammatory genes that are up-regulated in our study 
are Wnt, Lef1, and orosmucoid1 In the skin, Wnt and Lef1 are essential for development 
of hair follicles (Reddy et al., 2001).  Wnt 5a is up-regulated in the lesion of psoriatic 
skin (Reischl et al., 2007).  Lef1 is a DNA-binding protein which is regulated by beta-
catenin (cytoskeletal component and transcription factor), the downstream effector of 
canonical Wnt signaling (Nusse, 1999).  Beta-catenin is a gene expressed during the  
inflammatory process.  However, a change in beta-catenin gene was not observed in this 
study. The detailed process of interaction of beta-catenin and Wnt signaling is yet to be 
understood.  IL-1 beta alters beta-catenin to increase vascular permeability during 
inflammation (Barbieri and Weksler, 2007).  Orosomucoid1 or Alpha-1-acid glycoprotein 
(AGP) is a natural anti-inflammatory and immunomodulatory agent (Williams et al., 
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1997).  The antagonist used in the study is a drug developed for treatment of arthritis in 
humans.  The efficacy of the antagonist in a rat model is yet to be clearly understood.   
 
Conclusion 
One-hour occlusive JP-8 exposure does not induce neutrophil infiltration by 24 h 
post exposure.  The change in the level of CXCL2, although small compared to IL-1α 
levels, indicates that the cytokine could play a role at the early stage of the inflammatory 
cascade. We conclude that the one of the early events after the JP-8 exposure might be 
the release of the preformed and stored IL-1 α. 
 
Related  Studies 
IL-1 is released from skin in response to irritants such as benzalkonium chloride 
and sensitizers such as oxazolone (Wilmer et al., 1994).  The released cytokine could 
further induce is production of IL-1 through the autocrine loop.  To understand the 
autocrine role of preformed IL-1α released in response to JP-8 exposure, we delivered 
the IL-1ra into the skin before JP-8 exposure.  Phosphate buffered saline was injected as 
sham treatment.  JP-8 was applied in a patch over the injected regions.  An additional 
empty patch or patch containing JP-8 was placed on the non-injected region of the skin to 
study and compare the basal level of the cytokine without injection.  As there is a 
decrease in the amount of cytokine at 3h post exposure time point we measured the level 
of IL-1α at 3h post exposure time point.  There is no statistical significant difference 
between the four groups.  Until the efficacy of the human IL-1ra is tested on rat system, 
we have at least two possible reasons for the outcome.  One possibility is that the 
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delivered receptor antagonist may not have efficiently bound to the receptor and failed to 
bring its effect.  The second probability is that the change in the cytokine level might be 
occurring at a different time point.  Evaluating the efficacy of the antagonist and the 
repeating the study is necessary to interpret the current data.   
 
We also used tempol, an antioxidant to understand if any dose response reduction 
effect on the expression of IL-1α.  Tempol, can be delivered intradermally into the skin to 
scavenge ROS.  It has been has shown that in cultured fibroblasts, tempol reduced UV 
induced ROS generation (Yan et al., 2005).  We delivered tempol intradermally before 
JP-8 exposure.  The IL-1α and IL-1β levels (figure 15 and 17) in sham treatment and 
tempol treated skin is not significantly different after JP-8 exposure.  However, there is a 
trend in the expression (figure 14 and 16) of the cytokines.  Interestingly 5 mM and 50 
mM of tempol injection induced the increased expression of the IL-1α and IL-1β 
compared to sham and 25 mM tempol injection.  Lipopolysaccharide (LPS), a bacterial 
lipoglycan induces ROS synthesis.  To confirm the results we will have to repeat the 
experiment with a positive control such as lipopolysaccharide, a bacterial lipoglycan that 




Changes in ions in response to JP-8 exposure 
Preformed IL-1α, a known inflammation inducer in skin, was believed to play an 
important role in ICD.  In our study, we have shown that the level of IL-1α decreases on 
exposure to JP-8.  IL-1α has no leader peptide to aid secretion, and the mechanism of 
release of IL-1α  is not yet documented.  JP-8 on entering the dermal layer may change 
the ionic balance as a result membrane disruption (Monteiro-Riviere et al., 2004).  The 
change in the ionic balance associated with membrane disruption may in turn can induce 
the release of IL-1α.  Studying the changes in ionic balance in skin may help us to 
understand the molecular changes that happen after JP-8 exposure(Denda et al., 2000).  
Changes in pH, calcium, potassium, sodium and magnesium ions may be studied by 
blotting skin sections on to a gel containing chemical indicators.  For future study, 
understanding the role of ionic change in the release of IL-1α will provide understanding 
of the early events in JP-8 induced inflammatory process.  
Study of efficacy of IL-1 RA 
 
Documenting the efficacy of the receptor antagonist may be an area of interest for 
future studies.  The blocking effect of the selected antagonist has to be studied.  Injection 
of IL-1α will trigger inflammation (Willet et al., 2002).  Studying the inflammatory 
response induced by IL-1α in the IL-1 receptor antagonist treated tissue will be useful in 







ELISA Optimization tables (7-9): 
Table 6. ELISA Optimization table for IL-1 alpha: Monoclonal Capture (MAB 500)/ Polyclonal Detection (BAF 500) 
 
             100 ng/ml detection ab               150 ng/ml detection ab  
             






























































































































































































































































































             
            200 ng/ml detection ab               250 ng/ml detection ab  
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Table 7. ELISA Optimization table for IL-1 beta: Polyclonal Capture (AF-501-NA)/ Polyclonal Detection (BAF 501) 
 
 
             50 ng/ml detection ab               100 ng/ml detection ab  
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Table 8. ELISA Optimization table for CXCL2: Monoclonal Capture (MAB 525)/ Polyclonal Detection (BAF 525) 
 
 
             100 ng/ml detection ab               200 ng/ml detection ab  
             




















































1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
C 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
D 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 








































1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
1 ng/mL  
standard 
G 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
2 ng/mL  
standard 
H 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
4 ng/mL  
standard 
             
            300 ng/ml detection ab                400 ng/ml detection ab  
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Table 9: Summary of the quality control reports form Affymetrix Rat230_2.0 
GeneChips 
Metric Sample N Mean SD Minimum Maximum 
Background 
 
PBS 3 65.73 0.90 63.07 67.70 
Kineret 3 67.93 0.70 65.30 69.50 
Noise (Raw Q) 
 
PBS 3 2.15 0.08 2.06 2.20 
Kineret 3 2.17 0.05 2.11 2.22 
% Present 
 
PBS 3 65.56 0.70 64.70 66.20 
Kineret 3 65.83 0.50 65.30 66.40 
% Absent 
 
PBS 3 31.77 0.83 31.10 32.70 
Kineret 3 31.50 0.45 31.00 31.90 
% marginal 
 
PBS 3 2.67 0.05 2.60 2.70 
Kineret 3 2.63 0.15 2.50 2.80 
3'/5' Ratio 
GAPDH 
PBS 3 1.48 0.42 1.06 1.90 
Kineret 3 1.14 0.02 1.12 1.17 
 
Table 10: List of transcripts changed in gene expression study: 
 Gene name Fold change Description 
1 LOC502543 3.675 similar to SPRR1b 
2 Lef1 3.671 lymphoid enhancer binding factor 1 
3 Tm4sf4 3.658 
transmembrane 4 superfamily member 
4 
4 Tdh_predicted 3.6 L-threonine dehydrogenase (predicted) 
5 Mycn 3.406 
v-myc myelocytomatosis viral related 
oncogene, neuroblastoma derived 
(avian) 
6 RGD1307551_predicted 3.094 
similar to retinoic acid-responsive 
protein; STRA6 (predicted) 
7 RGD1307551_predicted 3.033 
similar to retinoic acid-responsive 
protein; STRA6 (predicted) 
8  2.977 Transcribed locus 
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 Gene name Fold change Description 
9 LOC499291 2.918 LOC499291 
10  2.896 Transcribed locus 
11 Dnajc6_predicted 2.815 
DnaJ (Hsp40) homolog, subfamily C, 
member 6 (predicted) 
12  2.798 Transcribed locus 
13 Lef1 2.725 Lymphoid enhancer binding factor 1 
14 Wnt5a 2.724 
Wingless-type MMTV integration site 
5A 
15 LOC498982 2.66 
similar to Myb proto-oncogene protein 
(C-myb) 
16 RGD1308116_predicted 2.657 
similar to hypothetical protein 
MGC42105 (predicted) 
17  2.493 Transcribed locus 
18 Selenbp1 2.429 selenium binding protein 2 
19 LOC499663 2.391 LOC499663 
20 Dlx1_predicted 2.39 distal-less homeobox 1 (predicted) 
21  2.378   
22  2.282   
23 RGD1307551_predicted 2.232 
similar to retinoic acid-responsive 
protein; STRA6 (predicted) 
24 Tagln3 2.222 transgelin 3 
25  2.213   
26  2.212 Desmocollin 2 (predicted) 
27 Lrat ; LOC497758 2.204 
lecithin-retinol acyltransferase ; 
hypothetical gene supported by 
NM_022280 
28  2.08 
Similar to KIAA0802 protein 
(predicted) 
29 Cdh22 2.055 cadherin 22 
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 Gene name Fold change Description 
30 Msx2 2.051 
Msh homeo box homolog 2 
(Drosophila) 
31 Msx2 2.049 
msh homeo box homolog 2 
(Drosophila) 
32 Orm1 2.044 orosomucoid 1 
33 RGD1304723_predicted 2.036 
similar to 4921507I02Rik protein 
(predicted) 
34 Ptch 2.019 Patched homolog 1 (Drosophila) 
35 LOC498911 2.005 LOC498911 
36 Mg29 0.498 Mitsugumin 29 (predicted) 
37 Fhl1 0.495 four and a half LIM domains 1 
38 LOC361187 0.495 
similar to ankyrin repeat and SOCs 
box-containing protein 5 
39 Hmox1 0.495 heme oxygenase (decycling) 1 
40  0.484 Nebulin (predicted) 
41 Ca3 0.482 carbonic anhydrase 3 
42 LOC499702 0.479 similar to Synaptopodin-2 (Myopodin) 
43  0.479 
Bol, boule-like (Drosophila) 
(predicted) 
44 Pfkm 0.474 phosphofructokinase, muscle 
45 RGD:620885 0.471 fast myosin alkali light chain 
46 Pdlim7 0.466 PDZ and LIM domain 7 
47  0.465 
Similar to 106 kDa O-GlcNAc 
transferase-interacting protein 
(predicted) 
48 Hspb3 0.465 
heat shock 27kD protein family, 
member 3 
49 RGD:69247 0.462 
potassium inwardly rectifying channel, 
subfamily J, member 11 
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 Gene name Fold change Description 
50 Slc2a4 0.46 
solute carrier family 2 (facilitated 
glucose transporter), member 4 
51  0.45   
52 Pfkm 0.448 phosphofructokinase, muscle 
53  0.447 
Similar to myocytic 
induction/differentiation originator 
(predicted) 
54  0.446 Transcribed locus 
55 Smyd1_predicted 0.442 
SET and MYND domain containing 1 
(predicted) 
56  0.429 Transcribed locus 
57 Myl2 0.426 myosin, light polypeptide 2 
58 Dbt 0.425 
dihydrolipoamide branched chain 
transacylase E2 
59 LOC503446 0.424 
similar to ankyrin repeat domain-
containing SOCS box protein 12 
60  0.421   
61 Mybpc1 0.419 myosin binding protein C, slow type 
62 Obscn 0.414 
obscurin, cytoskeletal calmodulin and 
titin-interacting RhoGEF 
63 Tpm1 0.408 Tropomyosin 1, alpha 
64 RGD1307901_predicted 0.406 
similar to RIKEN cDNA 1110001E17 
(predicted) 
65 Tnni1 0.402 troponin I, skeletal, slow 1 
66 Art1_predicted 0.395 ADP-ribosyltransferase 1 (predicted) 
67 Nrap_predicted 0.395 
nebulin-related anchoring protein 
(predicted) 
68  0.39 Transcribed locus 
69 RGD1307979_predicted 0.388 similar to muscle-derived protein 
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 Gene name Fold change Description 
MDP77 variant 1 (predicted) 
70 Ckm 0.387 creatine kinase, muscle 
71 LOC498066 0.386 similar to putative SH3BGR protein 
72 Tpm1 0.385 tropomyosin 1, alpha 
73 RGD:1303245 0.384 reticulon 2 (Z-band associated protein) 
74  0.376 Transcribed locus 
75 Tnnc2_predicted 0.373 troponin C2, fast (predicted) 
76 Pygm 0.373 muscle glycogen phosphorylase 
77 Myl3 0.372 myosin, light polypeptide 3 
78  0.368 Transcribed locus 
79 LOC361187 0.368 
similar to ankyrin repeat and SOCs 
box-containing protein 5 
80 Myh4 0.365 myosin, heavy polypeptide 4 
81 RGD1307979_predicted 0.364 
similar to muscle-derived protein 
MDP77 variant 1 (predicted) 
82 RGD1305774_predicted 0.363 hypothetical LOC287353 (predicted) 
83 Hspb6 0.363 
heat shock protein, alpha-crystallin-
related, B6 
84  0.361 
Cardiomyopathy associated 1 
(predicted) 
85  0.356 Transcribed locus 
86 Mx1 0.354 
myxovirus (influenza virus) resistance 
1 
87  0.354 Similar to mKIAA0613 protein 
88 Tnni1 0.349 troponin I, skeletal, slow 1 
89 Ddit4l 0.349 
DNA-damage-inducible transcript 4-
like 
90 Aqp4 0.348 Aquaporin 4 
91 RGD1311701_predicted 0.346 similar to RIKEN cDNA 1110030K22 
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 Gene name Fold change Description 
(predicted) 
92 Capn3 0.339 calpain 3 
93 Trdn 0.338 triadin 
94 Tmod4_predicted 0.335 tropomodulin 4 (predicted) 
95 Tnni2 0.334 troponin 1, type 2 
96 Myh7 0.33 
myosin, heavy polypeptide 7, cardiac 
muscle, beta 
97  0.325 Sarcalumenin (predicted) 
98  0.324 Transcribed locus 
99 Actn3 0.319 actinin alpha 3 
100 Csrp3 0.318 cysteine-rich protein 3 
101 Hrc 0.316 histidine rich calcium binding protein 
102  0.315   
103 Atp2a1 0.314 
ATPase, Ca++ transporting, cardiac 
muscle, fast twitch 1 
104  0.313 Similar to OTTMUSP00000000621 
105  0.308 Transcribed locus 
106  0.308 
Aspartate-beta-hydroxylase 
(predicted) 
107 Ppp1r1a 0.307 
protein phosphatase 1, regulatory 
(inhibitor) subunit 1A 
108 Pde4dip 0.306 
phosphodiesterase 4D interacting 
protein (myomegalin) 
109 Boll_predicted 0.306 
bol, boule-like (Drosophila) 
(predicted) 
110 Stars 0.305 
striated muscle activator of Rho-
dependent signaling 
111 Tnnt3 0.304 troponin T3, skeletal, fast 
112 RGD1306989_predicted 0.304 similar to DKFZP566O084 protein 
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 Gene name Fold change Description 
(predicted) 
113 Myh1 0.301 type 2X myosin heavy chain 
114 Lao1_predicted 0.301 L-amino acid oxidase 1 (predicted) 
115  0.3 
Transcribed locus, strongly similar to 
NP_009035.3 ribosomal protein L10a; 
60S ribosomal protein L10a [Homo 
sapiens] 
116 Myom2 0.3 Myomesin 2 
117 LOC498440 0.294 similar to myozenin 1 
118  0.293 Transcribed locus 
119 Eno3 0.293 enolase 3, beta 
120 LOC296935 0.292 
similar to Leiomodin 1 (Leiomodin, 
muscle form) (64 kDa autoantigen D1) 
(64 kDa autoantigen 1D) (64 kDa 
autoantigen 1D3) (Thyroid-associated 
ophthalmopathy autoantigen) (Smooth 
muscle leiomodin) (SM-Lmod) 
121 Six1 0.291 
sine oculis homeobox homolog 1 
(Drosophila) 
122  0.286   
123 RGD1306911_predicted 0.285 similar to CG10671-like (predicted) 
124 Trim63 0.284 tripartite motif-containing 63 
125 Pgam2 0.283 phosphoglycerate mutase 2 
126  0.283 
Transcribed locus, strongly similar to 
NP_077248.1 popeye domain 
containing 3 [Mus musculus] 
127 Pygm 0.277 muscle glycogen phosphorylase 
128 RGD1311911_predicted 0.276 




 Gene name Fold change Description 
129 Ttn 0.275 titin 
130 Myom1 0.275 myomesin 1 (skelemin) 185kDa 
131  0.273 Transcribed locus 
132 Pygm 0.27 muscle glycogen phosphorylase 
133 Enh 0.269 Enigma homolog 
134  0.268 Transcribed locus 
135  0.265 Transcribed locus 
136 Ampd1 0.263 
adenosine monophosphate deaminase 
1 (isoform M) 
137  0.261 
Troponin C, cardiac/slow skeletal 
(predicted) 
138 Ttid_predicted 0.258 
titin immunoglobulin domain protein 
(myotilin) (predicted) 
139 Pvalb 0.258 parvalbumin 
140 MGC109519 0.254 
similar to tropomyosin 1, embryonic 
fibroblast - rat 
141  0.245 Myopalladin (predicted) 
142 Mylk2 0.244 
myosin light chain kinase 2, skeletal 
muscle 
143 Cacng1 0.241 
calcium channel, voltage-dependent, 
gamma subunit 1 
144 Mybpc2_predicted 0.241 
myosin binding protein C, fast-type 
(predicted) 
145 Ckmt2 0.241 
Creatine kinase, mitochondrial 2, 
sarcomeric 
146 Mb 0.241 myoglobin 
147 Rpl3l_predicted 0.24 ribosomal protein L3-like (predicted) 
148 Smpx 0.239 small muscle protein, X-linked 
149 Rgmc_predicted 0.238 RGM domain family, member C 
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 Gene name Fold change Description 
(predicted) 
150  0.237   
151 Myh4_predicted 0.234 
myosin, heavy polypeptide 4, skeletal 
muscle (predicted) 
152 Myh6 ; Myh7 0.233 
myosin heavy chain, polypeptide 6 ; 
myosin, heavy polypeptide 7, cardiac 
muscle, beta 
153 Ryr1 0.228 ryanodine receptor 1, skeletal muscle 
154 Myf6 0.225 myogenic factor 6 
155 Kbtbd10 0.225 
kelch repeat and BTB (POZ) domain 
containing 10 
156 Rnf30_predicted 0.223 ring finger protein 30 (predicted) 
157 Apobec2_predicted 0.218 
apolipoprotein B editing complex 2 
(predicted) 
158  0.217   
159  0.215 
Bol, boule-like (Drosophila) 
(predicted) 
160 Trdn 0.208 Triadin 
161 Actn2_predicted 0.206 actinin alpha 2 (predicted) 
162 Cox6a2 0.203 
cytochrome c oxidase, subunit VIa, 
polypeptide 2 
163 Mlc2 0.199 
myosin regulatory light chain 2, 
ventricular/cardiac muscle isoform 
164 Cox8h 0.186 
Cytochrom c oxidase subunit VIII-H 
(heart/muscle) 
165 Trdn 0.185 triadin 
166 Ttn 0.176 titin 
167 Myoz2_predicted 0.176 myozenin 2 (predicted) 
168 Tnnt1 0.168 troponin T1, skeletal, slow 
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 Gene name Fold change Description 
169  0.158 Transcribed locus 
170 Myh7  
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